Edward Li

4PUBLICATIONS
11CO-AUTHORS
EndodonticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 14, 2026
Cost-Effectiveness of Biosimilar Denosumab Versus Bisphosphonates in Postmenopausal Osteoporosis.

Jeanine Flanigan, Sarah Kane, Fatemeh Mirzayeh Fashami

|Nov 19, 2025
A budget impact model for biosimilar denosumab for skeletal-related events and fractures in the United States oncology population.

Jeanine Flanigan, Stephen Chaplin, Joris van Stiphout

|May 07, 2021
Economic Analysis on Adoption of Biosimilar Granulocyte Colony-Stimulating Factors in Patients With Nonmyeloid Cancer at Risk of Febrile Neutropenia Within the Oncology Care Model Framework.

Weijia Wang, Edward Li, Kim Campbell

|Apr 01, 2021
Primary Prophylaxis With Biosimilar Filgrastim for Patients at Intermediate Risk for Febrile Neutropenia: A Cost-Effectiveness Analysis.

Edward Li, Dylan J Mezzio, David Campbell

Pageof 1

Frequent Collaborators

2 joint publications

Gary H Lyman

2 joint publications

Jeanine Flanigan

2 joint publications

Marion Schauf

2 joint publications

Mike Tindal